The study broadens the understanding of the genetic architecture of Brugada syndrome by identifying new risk loci and molecular mechanisms.
Expands BrS genetic architecture; leaves open functional validation and any clinical translation.
1.5 expression as a new underlying molecular mechanism. Taken together, these findings broaden our understanding of the genetic architecture of BrS and provide new insights into its molecular underpinnings.
No takes yet. Share an insight, caveat, or question.
Barc et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: